We are live on ! Find out more
SPC

Slate Path Capital Portfolio holdings

AUM $6.73B
1-Year Est. Return 95.97%
This Fund
S&P 500
This Quarter Est. Return
-6.8%
1 Year Est. Return
+95.97%
3 Year Est. Return
+272.8%
5 Year Est. Return
+330.15%
10 Year Est. Return
+4,591.92%
AUM
$2.22B
AUM Growth
-$1.35B
Cap. Flow
-$1.27B
Cap. Flow %
-57.33%
Top 10 Hldgs %
79.23%
Holding
26
New
8
Increased
4
Reduced
2
Closed
6

Top Sells

Rank Stock Value
1
TCOM icon
Trip.com Group
TCOM
+$93.8M
2
ALLE icon
Allegion
ALLE
+$93.5M
3
ENDP
Endo International plc
ENDP
+$77.7M
4
ISRG icon
Intuitive Surgical
ISRG
+$55.4M

Sector Composition

Rank Sector Weight
1 Communication Services 16.75%
2 Healthcare 12.94%
3 Energy 8.35%
4 Materials 5.03%
5 Technology 4.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DIA icon
1
PUT
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
$45.3B
$510M 22.95%
+3,000,000
New +$508M
SPY icon
2
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$778B
$296M 13.29%
1,500,000
-350,000
-19% -$69.2M
IWM icon
3
PUT
iShares Russell 2000 ETF
IWM
$79.4B
$164M 7.38%
+1,500,000
New +$172M
CHTR icon
4
Charter Communications
CHTR
$17.2B
$138M 6.2%
910,000
WBA
5
DELISTED
Walgreens Boots Alliance
WBA
$133M 5.99%
+2,245,000
New +$147M
P
6
DELISTED
Pandora Media Inc
P
$123M 5.55%
5,105,000
+1,280,000
+33% +$34M
AIG icon
7
American International
AIG
$42.8B
$106M 4.76%
1,960,000
B
8
Barrick Mining
B
$60.4B
$103M 4.63%
7,027,000
SIRI icon
9
SiriusXM
SIRI
$10.8B
$101M 4.54%
2,894,000
ISRG icon
10
Intuitive Surgical
ISRG
$127B
$87.7M 3.95%
1,710,000
-1,116,000
-39% -$55.4M
MPC icon
11
Marathon Petroleum
MPC
$90.4B
$87.2M 3.92%
2,060,000
+1,090,000
+112% +$46.3M
ALNY icon
12
Alnylam Pharmaceuticals
ALNY
$38.1B
$66.8M 3%
855,000
+257,000
+43% +$16.6M
ANDV
13
DELISTED
Andeavor
ANDV
$64.3M 2.89%
+1,055,000
New +$65M
ZNGA
14
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
$61.6M 2.77%
+22,800,000
New +$68.3M
IPXL
15
DELISTED
Impax Laboratories, Inc.
IPXL
$55.2M 2.48%
+2,330,000
New +$59.7M
YOKU
16
DELISTED
YOUKU TUDOU INC.(CAYMAN ISLS)
YOKU
$49.4M 2.22%
2,755,000
+550,000
+25% +$11.1M
PBF icon
17
PBF Energy
PBF
$7.56B
$34.1M 1.53%
1,420,000
MDCO
18
DELISTED
Medicines Co
MDCO
$24M 1.08%
+1,075,000
New +$27.3M
TPCO
19
DELISTED
Tribune Publishing Company Common Stock
TPCO
$10.2M 0.46%
+506,531
New +$10.2M
CLF icon
20
Cleveland-Cliffs
CLF
$6.41B
$8.88M 0.4%
855,000
ALLE icon
21
Allegion
ALLE
$13.4B
-1,650,000
Closed -$93.5M
QQQ icon
22
PUT
Invesco QQQ Trust
QQQ
$440B
-2,500,000
Closed -$235M
SPY icon
23
CALL
State Street SPDR S&P 500 ETF Trust
SPY
$778B
-9,100,000
Closed -$1.78B
TCOM icon
24
Trip.com Group
TCOM
$29.2B
-2,930,000
Closed -$93.8M
ENDP
25
DELISTED
Endo International plc
ENDP
-1,110,000
Closed -$77.7M

Similar funds

Slate Path Capital's Q3 2014 Portfolio in Review

As of Q3 2014, Slate Path Capital held 26 positions worth $2.22B, down 38% from $3.58B the previous quarter. Its ten largest holdings account for 79% of the portfolio.

Slate Path Capital withdrew a net $1.27B in Q3 2014, closing 6 positions and reducing 2 holdings. Its most notable exit was Trip.com Group, an estimated $93.8M position sold in full.

By sector, the portfolio is most concentrated in Communication Services at 17% of assets, up from 10% a quarter earlier, followed by Healthcare and Energy.

Against the trend, Slate Path Capital opened a new position in Walgreens Boots Alliance worth $133M.

  • Slate Path Capital's largest Q3 2014 buy was Walgreens Boots Alliance: 2,245,000 shares worth $133M.
  • Slate Path Capital added most to Marathon Petroleum in Q3 2014, an estimated $46.3M increase.
  • Slate Path Capital's biggest Q3 2014 reduction was Intuitive Surgical, cutting an estimated $55.4M.
  • Slate Path Capital fully exited Trip.com Group in Q3 2014, selling an estimated $93.8M.
  • Slate Path Capital's ten largest holdings make up 79% of its $2.22B portfolio in Q3 2014.
  • Slate Path Capital opened 8 new positions and closed 6 in Q3 2014.
  • Slate Path Capital's portfolio value fell 38% quarter-over-quarter to $2.22B.

Based on Slate Path Capital's 13F filing for Q3 2014, filed 14 Nov 2014.